Information Journal Paper
APA:
Copy. (2017). Combination of sofosbuvir, pegylatedinterferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis. DARU JOURNAL OF PHARMACEUTICAL SCIENCE, 25(1), 11-11. SID. https://sid.ir/paper/275779/en
Vancouver:
Copy. Combination of sofosbuvir, pegylatedinterferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis. DARU JOURNAL OF PHARMACEUTICAL SCIENCE[Internet]. 2017;25(1):11-11. Available from: https://sid.ir/paper/275779/en
IEEE:
Copy, “Combination of sofosbuvir, pegylatedinterferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis,” DARU JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 25, no. 1, pp. 11–11, 2017, [Online]. Available: https://sid.ir/paper/275779/en